Evidence map›Paper›PMID 36936777›Full record

ArticleFrontiers in cellular and infection microbiology2023

Enhancing urinary tract infection diagnosis for negative culture patients with metagenomic next-generation sequencing (mNGS).

Kaipeng Jia, Shiwang Huang, Chong Shen, Hongjun Li, Zhe Zhang, Lei Wang, Gangjian Zhao, Zhouliang Wu, Yuda Lin, Han Xia and 3 more

Open access · goldFull text read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Metagenomic next-generation sequencing: new horizons in microbiology.Frontiers in cellular and infection microbiology · 2026
    Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kaipeng JiaDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Shiwang HuangDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Chong ShenDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Hongjun LiDepartment of Infectious Diseases, The Second Hospital of Tianjin Medical University, Tianjin, China.
Zhe ZhangDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Lei WangDepartment of Infectious Diseases, The Second Hospital of Tianjin Medical University, Tianjin, China.
Gangjian ZhaoDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Zhouliang WuDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Yuda LinDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Han XiaDepartment of Scientific Affairs, Hugobiotech Co., Ltd., Beijing, China.
Mingze TangDepartment of Scientific Affairs, Hugobiotech Co., Ltd., Beijing, China.
Huifen YangDepartment of Infectious Diseases, The Second Hospital of Tianjin Medical University, Tianjin, China.
Hailong HuDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Tianjin Medical University · CNSecond Hospital of Tianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Metagenomic next-generation sequencing (mNGS) is a promising technology that allows unbiased pathogen detection and is increasingly being used for clinical diagnoses. However, its application in urinary tract infection (UTI) is still scarce. Methods: The medical records of 33 patients with suspected UTI who were admitted to the Second Hospital of Tianjin Medical University from March 2021 to July 2022 and received urine mNGS were retrospectively analyzed. The performance of mNGS and conventional urine culture in diagnosing infection and identifying causative organisms was compared, and the treatment effects were evaluated in terms of changes in urinalyses and urinary symptoms. Results: In the detection of bacteria and fungi, mNGS detected at least one pathogen in 29 (87.9%) cases, including 19 (57.6%) with positive mNGS but negative culture results and 10 (30.3%) with both mNGS and culture positive results. The remaining 4 (12.1%) patients were negative by both tests. Overall, mNGS performed better than culture (87.9% vs. 30.3%, Conclusions: mNGS is a technology that has shown clear advantages over culture, particularly in the context of mixed infections and UTIs that are difficult to diagnose and treat. It helps to improve the detection of pathogens, guide changes in treatment strategies, and is an effective complement to urine culture.

Indexed as

Body FluidsCoinfectionUrinary Tract InfectionsEscherichia coliHigh-Throughput Nucleotide SequencingHumansMetagenomicsRetrospective StudiesSensitivity and Specificitydiagnosishigh throughput sequencing (HTS)metagenomic next-generation sequencing (mNGS)treatmenturinary tract infection (UTI)

Identifiers

PMID36936777
PMCPMC10020507
OpenAlexW4323045291

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read53
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.